Processing

Please wait...

PATENTSCOPE will be unavailable a few hours for maintenance reason on Saturday 31.10.2020 at 7:00 AM CET
Settings

Settings

Goto Application

1. WO2020198379 - TYK2 PSEUDOKINASE LIGANDS

Publication Number WO/2020/198379
Publication Date 01.10.2020
International Application No. PCT/US2020/024746
International Filing Date 25.03.2020
IPC
A61K 31/519 2006.01
AHUMAN NECESSITIES
61MEDICAL OR VETERINARY SCIENCE; HYGIENE
KPREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
31Medicinal preparations containing organic active ingredients
33Heterocyclic compounds
395having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
495having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine
505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
519ortho- or peri-condensed with heterocyclic rings
C07D 413/14 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
413Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
14containing three or more hetero rings
C07D 471/12 2006.01
CCHEMISTRY; METALLURGY
07ORGANIC CHEMISTRY
DHETEROCYCLIC COMPOUNDS
471Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/-C07D463/251
12in which the condensed system contains three hetero rings
Applicants
  • VENTYX BIOSCIENCES, INC. [US]/[US]
Inventors
  • MOHAN, Raju
  • NUSS, John
  • HARRIS, Jason
  • YUAN, Shendong
Agents
  • MALECHA, James
Priority Data
62/824,14426.03.2019US
Publication Language English (EN)
Filing Language English (EN)
Designated States
Title
(EN) TYK2 PSEUDOKINASE LIGANDS
(FR) LIGANDS DE PSEUDOKINASE TYK2
Abstract
(EN)
Described herein are TYK2 pseudokinase ligands and methods of utilizing TYK2 pseudokinase ligands in the treatment of diseases, disorders or conditions. Also described herein are pharmaceutical compositions containing such compounds.
(FR)
L'invention concerne des ligands de pseudokinase TYK2 et des procédés d'utilisation de ligands de pseudokinase TYK2 dans le traitement de maladies, de troubles ou d'états. L'invention concerne également des compositions pharmaceutiques contenant de tels composés.
Latest bibliographic data on file with the International Bureau